These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30277131)

  • 41. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.
    van Doorn R; Dijkman R; Vermeer MH; Starink TM; Willemze R; Tensen CP
    Cancer Res; 2002 Oct; 62(19):5389-92. PubMed ID: 12359741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IL-10 is required for polarization of macrophages to M2-like phenotype by mycobacterial DnaK (heat shock protein 70).
    Lopes RL; Borges TJ; Zanin RF; Bonorino C
    Cytokine; 2016 Sep; 85():123-9. PubMed ID: 27337694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Interleukin-19 Expression in Cutaneous T-cell Lymphoma and Atopic Dermatitis.
    Oka T; Sugaya M; Takahashi N; Nakajima R; Otobe S; Kabasawa M; Suga H; Miyagaki T; Asano Y; Sato S
    Acta Derm Venereol; 2017 Nov; 97(10):1172-1177. PubMed ID: 28597022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
    Tensen CP; Vermeer MH; van der Stoop PM; van Beek P; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1998 Aug; 111(2):222-6. PubMed ID: 9699721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
    Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
    Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
    Liu X; Jin S; Hu S; Li R; Pan H; Liu Y; Lai P; Xu D; Sun J; Liu Z; Gao Y; Zhao Y; Liu F; Xiao Y; Li Y; Wen Y; Chen Z; Xu B; Lin Y; Ran M; Li Q; Yang S; Li H; Tu P; Haniffa M; Teichmann SA; Bai F; Wang Y
    Nat Commun; 2022 Mar; 13(1):1158. PubMed ID: 35241665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analyses.
    Nagatani T; Matsuzaki T; Iemoto G; Kim S; Baba N; Miyamoto H; Nakajima H
    Cancer; 1990 Dec; 66(11):2380-6. PubMed ID: 2245393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
    Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
    Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation.
    Oishi S; Takano R; Tamura S; Tani S; Iwaizumi M; Hamaya Y; Takagaki K; Nagata T; Seto S; Horii T; Osawa S; Furuta T; Miyajima H; Sugimoto K
    Immunology; 2016 Nov; 149(3):320-328. PubMed ID: 27421990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.
    Bagdonaite I; Wandall HH; Litvinov IV; Nastasi C; Becker JC; Dabelsteen S; Geisler C; Bonefeld CM; Zhang Q; Wasik MA; Zhou Y; Sasseville D; Ødum N; Woetmann A
    Oncotarget; 2015 Jun; 6(16):14374-84. PubMed ID: 25957418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
    Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
    Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice.
    Jackaman C; Radley-Crabb HG; Soffe Z; Shavlakadze T; Grounds MD; Nelson DJ
    Aging Cell; 2013 Jun; 12(3):345-57. PubMed ID: 23442123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
    Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
    J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.
    Kießling MK; Nicolay JP; Schlör T; Klemke CD; Süss D; Krammer PH; Gülow K
    Oncotarget; 2017 Jul; 8(28):45687-45697. PubMed ID: 28537899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased angiogenesis in cutaneous T-cell lymphomas.
    Mazur G; Woźniak Z; Wróbel T; Maj J; Kuliczkowski K
    Pathol Oncol Res; 2004; 10(1):34-6. PubMed ID: 15029259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy.
    Rossowska J; Anger N; Szczygieł A; Mierzejewska J; Pajtasz-Piasecka E
    J Exp Clin Cancer Res; 2018 Jun; 37(1):126. PubMed ID: 29954431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
    Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
    Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.